logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumabVitiligo and worsening of hypothyroidism following off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1886卷 / 1期
关键词:
D O I:
10.1007/s40278-021-07503-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:238 / 238
相关论文
共 50 条
  • [21] RisdiplamPneumonia following off-label use: case report
    Reactions Weekly, 2023, 1950 (1) : 348 - 348
  • [22] RivoceranibNeurotoxicity following an off-label use: case report
    Reactions Weekly, 2018, 1702 (1) : 232 - 232
  • [23] MethotrexateSteatohepatitis following off-label use: case report
    Reactions Weekly, 2019, 1768 (1) : 225 - 225
  • [24] AzacitidineDiarrhoea following off-label use: case report
    Reactions Weekly, 2019, 1736 (1) : 48 - 48
  • [25] TocilizumabNeutropenia following off-label use: case report
    Reactions Weekly, 2021, 1853 (1) : 446 - 446
  • [26] SunitinibCardiomyopathy following off-label use: case report
    Reactions Weekly, 2023, 1971 (1) : 240 - 240
  • [27] PrednisoloneInefficacy following off-label use: case report
    Reactions Weekly, 2022, 1910 (1) : 405 - 405
  • [28] DaratumumabHypogammaglobulinemia following off-label use: case report
    Reactions Weekly, 2019, 1744 (1) : 111 - 111
  • [29] NivolumabPsoriasis following an off-label use: case report
    Reactions Weekly, 2018, 1717 (1) : 214 - 214
  • [30] GlibenclamideHypoglycaemia following off-label use: case report
    Reactions Weekly, 2021, 1857 (1) : 162 - 162
← 12345 →